General Thoracic
Douglas Mathisen, MD (he/him/his)
Thoracic Surgeon
Massachusetts General Hospital
Boston, Massachusetts, United States
Disclosure(s): No financial relationships to disclose
Shaf Keshavjee, MD MSc FRCSC FACS
Chief of Innovation
University Health Network, University of Toronto
Toronto, Ontario, Canada
Disclosure(s): Abbott: Advisory Board (Ongoing); CareDx: Advisory Board (Ongoing); CSL Behring: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Lung Bioengineering: Consultant (Ongoing); SQI Diagnostics: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 22, 2023); Traferox Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); United Therapeutics: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Servet Bolukbas, MD, PhD, FEBTS, FECTS, MBA
Head, Department of Thoracic Surgery
University Medical Center Essen -Ruhrlandklinik
Essen, Germany
Disclosure(s): Astra Zeneca: Speaker (Ongoing); Bristol Myers Squibb: Speaker (Ongoing); KLS Martin: Consultant (Ongoing); Livsmed: Consultant (Ongoing); Roche: Speaker (Ongoing)
Richard Lazzaro, MD
Chief, Thoracic Surgery, Southern Region
Robert Wood Johnson Barnabas Health
Colts Neck, New Jersey, United States
Disclosure(s): No financial relationships to disclose
Jasleen Kukreja, MD
Professor of Surgery
University of California, San Francisco
San Francisco, California, United States
Disclosure(s): Guidepoint Consulting: Consultant (Ongoing); Lung Bioengineering: Advisory Board (Terminated, August 31, 2023)